POLR1F
DNA-directed RNA polymerase I subunit RPA43
Also known as: A43, RPA43, RPA43_HUMAN, TWISTNB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3B726
- Gene
- POLR1F
- Ensembl
- ENSG00000105849
- Chromosome
- 7
- Canonical length
- 338 aa
- Protein class
- Predicted intracellular proteins, RNA polymerase related proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center
OverviewNCBI Gene
Predicted to be involved in transcription elongation by RNA polymerase I. Predicted to act upstream of or within cellular response to leukemia inhibitory factor. Part of RNA polymerase I complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
338 residues, UniProt reviewed canonical sequence.
>Q3B726|POLR1F
1 MAAGCSEAPR PAAASDGSLV GQAGVLPCLE LPTYAAACAL VNSRYSCLVA GPHQRHIALS
61 PRYLNRKRTG IREQLDAELL RYSESLLGVP IAYDNIKVVG ELGDIYDDQG HIHLNIEADF
121 VIFCPEPGQK LMGIVNKVSS SHIGCLVHGC FNASIPKPEQ LSAEQWQTME INMGDELEFE
181 VFRLDSDAAG VFCIRGKLNI TSLQFKRSEV SEEVTENGTE EAAKKPKKKK KKKDPETYEV
241 DSGTTKLADD ADDTPMEESA LQNTNNANGI WEEEPKKKKK KKKHQEVQDQ DPVFQGSDSS
301 GYQSDHKKKK KKRKHSEEAE FTPPLKCSPK RKGKSNFLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POLR1F can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 16 nTPM
- tonsil: 12 nTPM
- urinary bladder: 11 nTPM
- endometrium: 11 nTPM
- smooth muscle: 11 nTPM
- placenta: 10 nTPM
Single-cell type
- decidual stromal cells: 211 nCPM
- endometrial stromal cells: 191 nCPM
- endometrial luminal cells: 182 nCPM
- monocytes: 157 nCPM
- oocytes: 143 nCPM
- suprabasal keratinocytes: 130 nCPM
Immune cell
- NK-cell: 18 nTPM
- naive B-cell: 13 nTPM
- naive CD8 T-cell: 13 nTPM
- memory B-cell: 13 nTPM
- MAIT T-cell: 12 nTPM
- naive CD4 T-cell: 11 nTPM
Brain region
- white matter: 11 nTPM
- hypothalamus: 9.3 nTPM
- midbrain: 9.3 nTPM
- spinal cord: 8.8 nTPM
- cerebral cortex: 8.2 nTPM
- basal ganglia: 8.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0.62
- DepMap mean gene effect
- -2.05
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to leukemia inhibitory factor
- DNA-templated transcription initiation
- transcription elongation by RNA polymerase I
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA polymerase Rpb7-like , N-terminal
- RNA polymerase Rpb7-like, N-terminal domain superfamily
- RNA polymerase subunit Rpb7-like
- SHS2 domain found in N terminus of Rpb7p/Rpc25p/MJ0397
- RPA43, OB domain
- Rpa43, N-terminal ribonucleoprotein (RNP) domain
- RPA43 OB domain in RNA Pol I
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POLR1F in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POLR1F as an antibody target. Whether an autoantibody or antibody against POLR1F could matter depends on whether native POLR1F is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POLR1F is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POLR1F as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...